Buy Stocks Easy | About Us
August 11, 2022
Buy Stocks Easy | Online Stocks

NCNA


Buy NuCana plc Stock (symbol: NCNA) Easy Online

Company Name: NuCana plc

Symbol: NCNA

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

NCNA Current Share Price

Today's NCNA ( NuCana plc ) opening price: $6.4800

Yesterday's NCNA ( NuCana plc ) closing price: $6.5200

NuCana plc Stock ( symbol: NCNA ) Price Chart since IPO (2017):

12 Months NuCana plc Stock ( symbol: NCNA ) Price Chart

Popular Questions about NuCana plc Public Stock ( NCNA )

A: NuCana plc stock symbol (also called stock or share ticker) is NCNA

A: NuCana plc IPO (Initial Public Offering) took place on 2017

A: NuCana plc's stock (NCNA symbol) price at ther IPO (initial Public Offering) was $6.4800

Q: Is NCNA stock worth buying at the moment?

A: The NCNA stock performance since 2019 are rather disappointing. If you had bought 1 share of NuCana plc stock (symbol: NCNA) at the beginning of 2019, at the opening share price of $12.9600, you would be left with exactly $6.4800 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy NuCana plc Stock Easy Online

NuCana plc Stock Ticker Price Chart since IPO:





NuCana plc Stock Price Yesterday



 


NuCana plc Stock Price – Last Week




 


NuCana plc Stock Price – Last Month




 


NuCana plc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936898/0/en/NuCana-Presents-Data-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html
                            

                                
NuCana Presents Data at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

                                
                                
NUC-3373: Favorable Pharmacokinetic Profile Demonstrated


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/25/1935600/0/en/NuCana-Announces-FDA-Clearance-to-Commence-Phase-III-Study-of-Acelarin-NUC-1031-for-the-First-Line-Treatment-of-Patients-with-Biliary-Tract-Cancer.html
                            

                                
NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer

                                
                                
Global NuTide:121 Study will Enroll up to 828 Patients and Compare ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/505064/nucana-plc-ncna-shares-march-higher-can-it-continue
                            

                                
NuCana plc (NCNA) Shares March Higher, Can It Continue?

                                
                                
As of late, it has definitely been a great time to be an investor i...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/29/1908340/0/en/NuCana-to-Present-at-the-Morgan-Stanley-17th-Annual-Global-Healthcare-Conference.html
                            

                                
NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

                                
                                
EDINBURGH, United Kingdom, Aug.  29, 2019  (GLOBE NEWSWIRE) -- NuCa...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/27/1907032/0/en/NuCana-to-Participate-in-Citi-s-14th-Annual-Biotech-Conference.html
                            

                                
NuCana to Participate in Citi’s 14th Annual Biotech Conference

                                
                                
EDINBURGH, United Kingdom, Aug.  27, 2019  (GLOBE NEWSWIRE) -- NuCa...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/21/1905091/0/en/NuCana-Reports-Second-Quarter-2019-Financial-Results-and-Provides-Business-Update.html
                            

                                
NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update

                                
                                
Numerous Clinical Data Announcements and Study Initiations Expected...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/481254/nucana-stops-patient-enrollment-in-pancreatic-cancer-study
                            

                                
NuCana Stops Patient Enrollment in Pancreatic Cancer Study

                                
                                
NuCana (NCNA) suspends patient enrollment in the phase III study on...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/nucana-stock-falls-21-after-company-suspends-patient-enrollment-in-pancreatic-cancer-trial-2019-08-20
                            

                                
NuCana stock falls 21% after company suspends patient enrollment in pancreatic cancer trial

                                
                                
Shares of NuCana Plc fell 21% on Tuesday after the company announce...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/20/1904090/0/en/Enrollment-in-the-Independent-Investigator-Sponsored-Phase-III-Metastatic-Pancreatic-Study-ACELARATE-Has-Been-Suspended-Following-a-Prespecified-Futility-Analysis.html
                            

                                
Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis

                                
                                
Imbalances in Prognostic Factors May Have Impacted Analysis


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/930270/analysts-recommend-these-2-falling-knives-
                            

                                
Analysts Recommend These 2 Falling Knives (Aug 18)

                                
                                
Falling Knives are companies whose share prices have fallen more th...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.